title: Intereleukin-10 promoter polymorphism in mild cognitive impairment and in its clinical evolution.
abstract: Specific proinflammatory alleles are associated with higher risk of Alzheimer disease (AD) in different onset age. The homozygosis for the A allele of -1082 polymorphism (G/A) of interleukin-10 (IL-10) promotes a higher risk of AD and reduced IL-10 generation in peripheral cells after amyloid stimulation. In this paper we analysed genotype and allele frequencies of this polymorphism in 138 subjects with mild cognitive impairment (MCI) diagnosed, respectively, as amnestic (a-MCI) and multiple impaired cognitive domains (mcd-MCI). The genotype frequencies were similar in a-MCI and AD subjects, whereas in mcd-MCI comparable to controls (AA genotype: 50% in a-MCI, 49.2% in AD, 28.7% in mcd-MCI and 31.8% in controls). Consequently, both allele and genotype distributions were significantly different between a-MCI and mcd-MCI (allele: P = .02, genotype: P < .05). These results support the theory that polymorphisms of cytokine genes can affect neurodegeneration and its clinical progression. IL-10 may partly explain the conversion of a-MCI to AD or be a genetic marker of susceptibility.
authors.affiliation: Department of Internal Medicine, Università degli Studi di Milano, Geriatric Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Via Pace 9, 20122 Milano, Italy.
authors.forename: Beatrice
authors.initials: B
authors.lastname: Arosio
authors.forename: Luigina
authors.initials: L
authors.lastname: Mastronardi
authors.forename: Carlo
authors.initials: C
authors.lastname: Vergani
authors.forename: Giorgio
authors.initials: G
authors.lastname: Annoni
references.citation: Nat Med. 2007 Nov;13(11):1359-62
references.pmid: 17934472
references.citation: J Neuroimmunol. 2008 Jan;193(1-2):183-7
references.pmid: 18037502
references.citation: Nucleic Acids Res. 1988 Feb 11;16(3):1215
references.pmid: 3344216
references.citation: J Am Geriatr Soc. 2006 Apr;54(4):580-6
references.pmid: 16686866
references.citation: Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9465-70
references.pmid: 9689103
references.citation: J Neuroimmunol. 2001 Feb 1;113(1):49-62
references.pmid: 11137576
references.citation: Neurology. 1984 Jul;34(7):939-44
references.pmid: 6610841
references.citation: J Neural Transm (Vienna). 2008 Jun;115(6):863-7
references.pmid: 18299793
references.citation: Arch Neurol. 2001 Dec;58(12):1985-92
references.pmid: 11735772
references.citation: J Immunol. 1993 Aug 1;151(3):1473-81
references.pmid: 8335941
references.citation: Dement Geriatr Cogn Disord. 2001 Sep-Oct;12(5):314-7
references.pmid: 11455132
references.citation: Neuron. 2009 Aug 13;63(3):287-303
references.pmid: 19679070
references.citation: Lancet Neurol. 2006 Mar;5(3):228-34
references.pmid: 16488378
references.citation: Ann Neurol. 1999 Mar;45(3):358-68
references.pmid: 10072051
references.citation: J Immunol. 1992 Jun 1;148(11):3618-23
references.pmid: 1350294
references.citation: Nat Med. 2006 Sep;12(9):1005-15
references.pmid: 16960575
references.citation: Tissue Antigens. 1997 Jun;49(6):635-9
references.pmid: 9234486
references.citation: Neurobiol Aging. 2004 Sep;25(8):1009-15
references.pmid: 15212825
references.citation: J Intern Med. 2004 Sep;256(3):183-94
references.pmid: 15324362
references.citation: Neurology. 2009 Mar 3;72(9):829-34
references.pmid: 19255410
references.citation: Genes Immun. 2003 Apr;4(3):234-8
references.pmid: 12700599
references.citation: Neurobiol Aging. 2007 Nov;28(11):1637-43
references.pmid: 16930778
references.citation: J Clin Immunol. 1999 Jul;19(4):223-30
references.pmid: 10471976
references.citation: N Engl J Med. 2010 Jan 28;362(4):329-44
references.pmid: 20107219
references.citation: Nat Rev Neurosci. 2009 May;10(5):333-44
references.pmid: 19339974
references.citation: Immunol Lett. 2008 May 15;117(2):198-202
references.pmid: 18367253
references.citation: Ann Hum Biol. 2006 May-Jun;33(3):279-308
references.pmid: 17092867
references.citation: Genes Immun. 2002 Feb;3(1):30-3
references.pmid: 11857058